Results 201 to 210 of about 14,701,690 (366)

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu   +11 more
wiley   +1 more source

Patterns in Tennessee's Black Population 2000-2010 [PDF]

open access: yes
The recent increase in the rate of growth in the black population has important implications for the state's population mix.Tennessee, population, black, black population, census, 2010, census 2010, population growth, population, growth, change, county ...
H. Ronald Moser
core  

The Effect of Population Growth on the Environment: Evidence from European Regions

open access: yesEuropean Journal of Population, 2018
Hannes Weber, Jennifer D. Sciubba
semanticscholar   +1 more source

Does Porphyromonas gingivalis truly inhibit the oral carcinogenesis?

open access: yesMolecular Oncology, EarlyView.
 
Chen‐xi Li, Zhong‐cheng Gong
wiley   +1 more source

Association between economic growth and early childhood nutrition – Authors' reply

open access: yesThe Lancet Global Health, 2014
Sebastian Vollmer   +5 more
doaj   +1 more source

Determination of ADP/ATP translocase isoform ratios in malignancy and cellular senescence

open access: yesMolecular Oncology, EarlyView.
The individual functions of three isoforms exchanging ADP and ATP (ADP/ATP translocases; ANTs) on the mitochondrial membrane remain unclear. We developed a method for quantitatively differentiating highly similar human ANT1, ANT2, and ANT3 using parallel reaction monitoring. This method allowed us to assess changes in translocase levels during cellular
Zuzana Liblova   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy